Jose Obeso, M.D., Ph.D.
Affiliations: | Neurociencias | CIMA, Universidad de Navarra, Pamplona, Navarra, Spain | |
| Neurology | Universidad CEU San Pablo (Spain) |
Area:
Parkinson's DiseaseWebsite:
http://gadeaciencia.org/teams/obeso-jose-a-2/Google:
"Jose A. Obeso"Bio:
https://www.michaeljfox.org/foundation/researchers.php?id=396
Mean distance: 15.11 (cluster 10) | S | N | B | C | P |
Parents
Sign in to add mentor| David C. Marsden | grad student | UCL Institute of Neurology, Queen Square |
Children
Sign in to add trainee| Elena Iglesias | research assistant | CIMA, Universidad de Navarra | |
| Rebeca Adanez | grad student | CIMA, Universidad de Navarra | |
| Javier Blesa | grad student | CIMA, Universidad de Navarra | |
| Beatriz Benitez Temiño | post-doc | CIMA, Universidad de Navarra | |
| Ledia F Hernandez | post-doc | 2006-2006 | CIMA, Universidad de Navarra |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lanciego JL, Obeso JA. (2024) Functional Neuroanatomy of the Normal and Pathological Basal Ganglia. Cold Spring Harbor Perspectives in Medicine |
| Del Rey NL, Hernández-Pinedo N, Carrillo M, et al. (2024) Calbindin and Girk2/Aldh1a1 define resilient vs vulnerable dopaminergic neurons in a primate Parkinson's disease model. Npj Parkinson's Disease. 10: 165 |
| Magrinelli F, Tesson C, Angelova PR, et al. (2024) variants cause a phenotypic spectrum from early-onset Parkinson's disease to perinatal lethality by disrupting mitochondrial pathways. Medrxiv : the Preprint Server For Health Sciences |
| Matarazzo M, Obeso JA. (2024) Alpha synuclein PET imaging, a step closer to in vivo neuropathology in Parkinson's disease and related disorders. Neuron. 112: 2457-2458 |
| Obeso I, Loayza FR, González-Redondo R, et al. (2024) The causal role of the subthalamic nucleus in the inhibitory network. Annals of the New York Academy of Sciences |
| Balzano T, Del Rey NL, Esteban-García N, et al. (2024) Neurovascular and immune factors of vulnerability of substantia nigra dopaminergic neurons in non-human primates. Npj Parkinson's Disease. 10: 118 |
| Nambu A, Chiken S, Sano H, et al. (2024) [Dynamic activity model of movement disorders: a unified view to understand their pathophysiology]. Rinsho Shinkeigaku = Clinical Neurology |
| Gasca-Salas C, Pineda-Pardo JA, Del Álamo M, et al. (2024) Nigrostriatal blood-brain barrier opening in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry |
| Martínez-Fernández R, Natera-Villalba E, Rodríguez-Rojas R, et al. (2024) Staged Bilateral MRI-Guided Focused Ultrasound Subthalamotomy for Parkinson Disease. Jama Neurology |
| Olanow CW, McIntyre D, Matarazzo M, et al. (2024) Continuous Levodopa Delivery with an Intraoral Micropump System: An Open-Label Pharmacokinetics and Clinical Study. Movement Disorders : Official Journal of the Movement Disorder Society |